As of November 2024, Evogene has a market cap of $144.92M. This makes Evogene the world's 19236th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $36.50M | -8.94% |
2023 | $40.08M | 34.14% |
2022 | $29.88M | -58.42% |
2021 | $71.86M | -65.19% |
2020 | $206.42M | 193.76% |
2019 | $70.27M | -32.44% |
2018 | $104.01M | -31.15% |
2017 | $151.07M | -42.35% |
2016 | $262.04M | -37.02% |
2015 | $416.05M | -13.87% |
2014 | $483.03M | -46.98% |
2013 | $911.11M | 83.30% |
2012 | $497.07M | 24.02% |
2011 | $400.81M | -26.52% |
2010 | $545.47M | 53.38% |
2009 | $355.62M | 95.59% |
2008 | $181.82M | 63.58% |
2007 | $111.15M | - |